Yongfen Xu

1.3k total citations
29 papers, 1.0k citations indexed

About

Yongfen Xu is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Yongfen Xu has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 10 papers in Infectious Diseases and 10 papers in Epidemiology. Recurrent topics in Yongfen Xu's work include Mosquito-borne diseases and control (10 papers), Hepatitis C virus research (10 papers) and interferon and immune responses (7 papers). Yongfen Xu is often cited by papers focused on Mosquito-borne diseases and control (10 papers), Hepatitis C virus research (10 papers) and interferon and immune responses (7 papers). Yongfen Xu collaborates with scholars based in China, Germany and United States. Yongfen Xu's co-authors include Jin Zhong, Zhanqing Zhang, Fang Shen, Zhenghong Yuan, Yunwen Hu, Jiefei Wang, Xiaonan Zhang, Zhiao Chen, Guangxun Meng and Wei Chen and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Yongfen Xu

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongfen Xu China 18 411 320 310 267 263 29 1.0k
Hui‐Lin Wu Taiwan 18 626 1.5× 307 1.0× 191 0.6× 218 0.8× 439 1.7× 34 1.1k
Erin M. McCartney Australia 12 237 0.6× 216 0.7× 285 0.9× 149 0.6× 193 0.7× 22 752
Brigitte Heller United States 17 343 0.8× 306 1.0× 165 0.5× 330 1.2× 347 1.3× 24 1.1k
Cathy Royer France 20 600 1.5× 284 0.9× 228 0.7× 264 1.0× 628 2.4× 41 1.5k
Luwen Zhang United States 19 347 0.8× 225 0.7× 360 1.2× 300 1.1× 113 0.4× 49 1.2k
Youhui Si China 15 133 0.3× 305 1.0× 226 0.7× 143 0.5× 80 0.3× 39 734
Alexander S. Kekulé Germany 13 767 1.9× 334 1.0× 104 0.3× 165 0.6× 427 1.6× 27 1.1k
Daniel L. Popkin United States 18 257 0.6× 284 0.9× 383 1.2× 154 0.6× 56 0.2× 37 1.1k
Zohreh Sharifi Iran 15 410 1.0× 159 0.5× 144 0.5× 132 0.5× 218 0.8× 130 844
Vladimir Chulanov Russia 18 744 1.8× 636 2.0× 102 0.3× 185 0.7× 594 2.3× 115 1.5k

Countries citing papers authored by Yongfen Xu

Since Specialization
Citations

This map shows the geographic impact of Yongfen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongfen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongfen Xu more than expected).

Fields of papers citing papers by Yongfen Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongfen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongfen Xu. The network helps show where Yongfen Xu may publish in the future.

Co-authorship network of co-authors of Yongfen Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongfen Xu. A scholar is included among the top collaborators of Yongfen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongfen Xu. Yongfen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Fanfan, Yongfen Xu, Zhi Liu, et al.. (2023). Extracellular vesicles from Zika virus‐infected cells display viral E protein that binds ZIKV‐neutralizing antibodies to prevent infection enhancement. The EMBO Journal. 42(6). e112096–e112096. 25 indexed citations
2.
Tong, Yimin, Gansheng Shi, Gaowei Hu, et al.. (2021). Photo-catalyzed TiO2 inactivates pathogenic viruses by attacking viral genome. Chemical Engineering Journal. 414. 128788–128788. 34 indexed citations
3.
Yang, Jing‐Jing, Yongfen Xu, Yunzheng Yan, et al.. (2020). Small Molecule Inhibitor of ATPase Activity of HSP70 as a Broad-Spectrum Inhibitor against Flavivirus Infections. ACS Infectious Diseases. 6(5). 832–843. 28 indexed citations
4.
Qi, Yue, Yanfei Qi, Xia Jin, et al.. (2020). Anti-flavivirus activity of polyoxometalate. Antiviral Research. 179. 104813–104813. 17 indexed citations
5.
Dong, Wei, Guang Hu, Yongfen Xu, et al.. (2020). Japanese Encephalitis Virus Vaccination Elicits Cross-Reactive HLA-Class I-Restricted CD8 T Cell Response Against Zika Virus Infection. Frontiers in Immunology. 11. 577546–577546. 8 indexed citations
6.
Tong, Yimin, Qingchao Li, Rui Li, et al.. (2020). A Novel Approach To Display Structural Proteins of Hepatitis C Virus Quasispecies in Patients Reveals a Key Role of E2 HVR1 in Viral Evolution. Journal of Virology. 94(17). 9 indexed citations
7.
Guo, Mingzhe, Jie Lu, Xiaogang Xiang, et al.. (2019). Construction and characterization of Genotype-3 hepatitis C virus replicon revealed critical genotype-3-specific polymorphism for drug resistance and viral fitness. Antiviral Research. 171. 104612–104612. 5 indexed citations
8.
Tang, Jinyi, Zhihua Liu, Yuanhua Liu, et al.. (2019). ZIKV infection induces robust Th1-like Tfh cell and long-term protective antibody responses in immunocompetent mice. Nature Communications. 10(1). 3859–3859. 36 indexed citations
9.
Li, Zheng, Guang Xue, Yongfen Xu, et al.. (2019). Antiviral effects of simeprevir on multiple viruses. Antiviral Research. 172. 104607–104607. 10 indexed citations
10.
Mao, Haiyan, et al.. (2019). FBLN3 inhibits the invasion and metastasis of colorectal cancer through the AKT/mTOR pathway. Neoplasma. 66(3). 336–342. 9 indexed citations
11.
Zhao, Yanan, Xuezhi Cao, Mingzhe Guo, et al.. (2018). Neuralized E3 Ubiquitin Protein Ligase 3 Is an Inducible Antiviral Effector That Inhibits Hepatitis C Virus Assembly by Targeting Viral E1 Glycoprotein. Journal of Virology. 92(21). 9 indexed citations
12.
Qu, Panke, Dapeng Li, Qingwei Liu, et al.. (2018). Insect cell-produced recombinant protein subunit vaccines protect against Zika virus infection. Antiviral Research. 154. 97–103. 30 indexed citations
13.
Zhao, Fanfan, Yongfen Xu, Dimitri Lavillette, et al.. (2018). Negligible contribution of M2634V substitution to ZIKV pathogenesis in AG6 mice revealed by a bacterial promoter activity reduced infectious clone. Scientific Reports. 8(1). 10491–10491. 23 indexed citations
14.
Li, Qingchao, Yimin Tong, Yongfen Xu, Junqi Niu, & Jin Zhong. (2018). Genetic Analysis of Serum-Derived Defective Hepatitis C Virus Genomes Revealed Novel Viral cis Elements for Virus Replication and Assembly. Journal of Virology. 92(7). 12 indexed citations
15.
Wang, Hongbin, Zheng Li, Junling Niu, et al.. (2018). Antiviral effects of ferric ammonium citrate. Cell Discovery. 4(1). 14–14. 44 indexed citations
16.
Xu, Yongfen & Jin Zhong. (2016). Innate immunity against hepatitis C virus. Current Opinion in Immunology. 42. 98–104. 31 indexed citations
17.
Chen, Wei, Yongfen Xu, Hua Li, et al.. (2014). HCV Genomic RNA Activates the NLRP3 Inflammasome in Human Myeloid Cells. PLoS ONE. 9(1). e84953–e84953. 72 indexed citations
18.
Xu, Yongfen, Hua Li, Wei Chen, et al.. (2013). Mycoplasma hyorhinis Activates the NLRP3 Inflammasome and Promotes Migration and Invasion of Gastric Cancer Cells. PLoS ONE. 8(11). e77955–e77955. 71 indexed citations
19.
Xu, Yongfen, Yunwen Hu, Bisheng Shi, et al.. (2009). HBsAg inhibits TLR9-mediated activation and IFN-α production in plasmacytoid dendritic cells. Molecular Immunology. 46(13). 2640–2646. 156 indexed citations
20.
Chen, Zhiao, Yu‐Ming Cheng, Yongfen Xu, et al.. (2008). Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. Clinical Immunology. 128(3). 400–408. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026